Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q2 2019 Atara Biotherapeutics Inc Earnings Call Transcript

Aug 08, 2019 / 12:00PM GMT
Release Date Price: $313.5 (+4.24%)
Operator

Good day, ladies and gentlemen, and welcome to the Atara Biotherapeutics Second Quarter 2019 Financial Results Conference Call. (Operator Instructions)

I would now like to turn the conference over to your host, Dr. John Craighead, Vice President, Investor Relations and Corporate Communications. You may begin.

John Craighead
Atara Biotherapeutics, Inc. - VP of IR & Corporate Communications

Thank you, operator. Good morning, everyone, and welcome to the Atara Second Quarter 2019 Financial Results and Corporate Update Conference Call. Earlier this morning, we issued a press release providing an overview of the company's second quarter 2019 financial results and recent operational progress. This press release as well as an updated investor presentation, are available in the Investors & Media section of atarabio.com. I'm joined on the call today by Dr. Pascal Touchon, President and Chief Executive Officer; Utpal Koppikar, Chief Financial Officer; Dr. Chris Haqq, Chief Scientific Officer; and Dr. AJ Joshi, Chief Medical Officer. We'll begin with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot